Segment and Geographic Information - Segment Information (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Sep. 30, 2025 |
Sep. 30, 2024 |
|
| Segment Information | ||||||||
| Income and revenues | $ 9,351,000 | $ 7,197,000 | $ 38,392,000 | $ 19,773,000 | ||||
| Other segment items: | ||||||||
| Research and development expenses | (69,000) | (817,000) | (1,431,000) | (2,011,000) | ||||
| Depreciation of property and equipment | (8,000) | (8,000) | ||||||
| Credit losses on purchased receivables | (14,000,000) | (23,000,000) | ||||||
| Amortization of intangible assets | (878,000) | (2,077,000) | ||||||
| Gains on acquisitions | 18,004,000 | 18,004,000 | 19,316,000 | |||||
| Change in fair value of embedded derivative related to RPA | 8,100,000 | |||||||
| Change in fair value of derivatives related to Castle Creek | (10,000) | |||||||
| Interest expense | (3,301,000) | (3,493,000) | (10,004,000) | (10,446,000) | ||||
| Other income, net | 727,000 | 1,890,000 | 8,456,000 | 5,900,000 | ||||
| Income tax expense | (49,000) | (49,000) | ||||||
| Net income (loss) | 14,051,000 | $ 9,191,000 | $ 2,367,000 | (17,243,000) | $ 15,985,000 | $ (8,595,000) | 25,609,000 | (9,853,000) |
| General and administrative | 9,734,000 | 8,020,000 | 25,682,000 | 27,485,000 | ||||
| Single Reportable Segment | ||||||||
| Segment Information | ||||||||
| Income and revenues | 9,351,000 | 7,197,000 | 38,392,000 | 19,773,000 | ||||
| Business development and deal related costs | (4,339,000) | (1,028,000) | (7,212,000) | (2,446,000) | ||||
| Other segment items: | ||||||||
| Research and development expenses | (69,000) | (817,000) | (1,431,000) | (2,011,000) | ||||
| Depreciation of property and equipment | (2,000) | (3,000) | (8,000) | (8,000) | ||||
| Other general and administrative expenses | (5,393,000) | (6,989,000) | (18,462,000) | (25,031,000) | ||||
| Credit losses on purchased receivables | (14,000,000) | (23,000,000) | ||||||
| Amortization of intangible assets | (878,000) | (2,077,000) | ||||||
| Gains on acquisitions | 18,004,000 | 18,004,000 | 19,316,000 | |||||
| Change in fair value of embedded derivative related to RPA | 8,100,000 | |||||||
| Change in fair value of derivatives related to Castle Creek | (15,000) | (10,000) | ||||||
| Interest expense | (3,301,000) | (3,493,000) | (10,004,000) | (10,446,000) | ||||
| Income tax expense | (49,000) | (49,000) | ||||||
| Net income (loss) | 14,051,000 | (17,243,000) | 25,609,000 | (9,853,000) | ||||
| Operating Segment | Single Reportable Segment | ||||||||
| Other segment items: | ||||||||
| Other income, net | $ 742,000 | $ 1,890,000 | $ 8,466,000 | $ 5,900,000 | ||||
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense for debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expenses pertaining to business development and the cost incurred in respect to deals. No definition available.
|
| X | ||||||||||
- Definition Amount of credit loss on purchased receivables relating to royalty and license purchase agreements. No definition available.
|
| X | ||||||||||
- Definition Gain (loss) included in earnings resulting from the asset acquisition. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|